The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Abstract
In 1990, a clinical trial was started using retroviral-mediated transfer of the adenosine deaminase (ADA) gene into the T cells of two children with severe combined immunodeficiency (ADA − SCID). The number of blood T cells normalized as did many cellular and humoral immune responses. Gene treatment ended after 2 years, but integrated vector and ADA gene expression in T cells persisted. Although many components remain to be perfected, it is concluded here that gene therapy can be a safe and effective addition to treatment for some patients with this severe immunodeficiency disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,971
Self-citationMann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,805
ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
Giblett, E., Anderson, J., Cohen, F., Pollara, B., & Meuwissen, H. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92345-8 · Cited by 1,636
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895 · Cited by 1,370
Self-citationRosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230904 · Cited by 1,318
Self-citationROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIA
Waldmann, T. A., Broder, S., Blaese, R. M., Durm, M., Blackman, M. A., & Strober, W. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91940-0 · Cited by 705
Self-citationClerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S., & Shearer, G. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114376 · Cited by 613
Self-citationKohn, D. B., Weinberg, K. I., Nolta, J. A., Heiss, L. N., Lenarsky, C., Crooks, G. M., Hanley, M. E., Annett, G., Brooks, J. S., El-Khoureiy, A., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1017 · Cited by 594
Self-citationTreatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine Deaminase
Hershfield, M. S., Buckley, R. H., Greenberg, M. L., Melton, A. L., Schiff, R., Hatem, C., Kurtzberg, J., Markert, M. L., Kobayashi, R. H., Kobayashi, A. L., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161005 · Cited by 443
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen, A., Hirschhorn, R., Horowitz, S. D., Rubinstein, A., Polmar, S. H., Hong, R., & Martin, D. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.472 · Cited by 399
CONGENITAL HYDRONEPHROSIS AND HYDRO-URETER WITH CONTRALATERAL PAIN
HUDSON, N. (1949) · The Lancet · doi:10.1016/s0140-6736(49)90266-4 · Cited by 386
Effect of internal viral sequences on the utility of retroviral vectors
Armentano, D., Yu, S. F., Kantoff, P. W., von Ruden, T., Anderson, W. F., & Gilboa, E. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1647-1650.1987 · Cited by 336
Self-citationColemán, M. S., Donofrio, J. C., Hutton, J. J., Hahn, L. C., Daoud, A., Lampkin, B. C., & Dyminski, J. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34910-4 · Cited by 278
Bunnell, B. A., Muul, L. M., Donahue, R. E., Blaese, R. M., & Morgan, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7739 · Cited by 258
Self-citationEnzyme Replacement Therapy for Adenosine Deaminase Deficiency and Severe Combined Immunodeficiency
Polmar, S. H., Stern, R. C., Schwartz, A. L., Wetzler, E. M., Chase, P. A., & Hirschhorn, R. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612092952402 · Cited by 248
Shimotohno, K., & Temin, H. M. (1981) · Cell · doi:10.1016/0092-8674(81)90034-9 · Cited by 245
Points to Consider Response with Clinical Protocol, July 6, 1990
Anderson, W. F., Blaese, R. M., & Culver, K. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.3-331 · Cited by 218
Self-citationLevy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Self-citationMiller, A. D., Jolly, D. J., Friedmann, T., & Verma, I. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4709 · Cited by 202
Self-citationWatanabe, S., & Temin, H. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5986 · Cited by 184
Carson, D. A., Kaye, J., & Wasson, D. B. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.1.348 · Cited by 142
Lymphocytes as cellular vehicles for gene therapy in mouse and man.
Culver, K. W., Cornetta, K. G., Morgan, R., Morecki, S., Aebersold, P. M., Kasid, A., Lotze, M. T., Rosenberg, S. A., Anderson, W. F., & Blaese, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3155 · Cited by 140
Self-citationCulver, K. W., Anderson, W. F., & Blaese, R. M. (1991) · Human Gene Therapy · doi:10.1089/hum.1991.2.2-107 · Cited by 128
Self-citationAn in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined Immunodeficiency
Ferrari, G., Rossini, S., Giavazzi, R., Maggioni, D., Nobili, N., Soldati, M., Ungers, G. E., Mavilio, F., Gilboa, E., & Bordignon, C. (1991) · Science · doi:10.1126/science.1848369 · Cited by 125
Biddison, W. E., Ward, F. E., Shearer, G. M., & Shaw, S. M. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.2.548 · Cited by 111
Self-citationFriedrich, W., Vetter, U. K., Heymer, B., Reisner, Y., Goldmann, S. F., Fliedner, T. M., Peter, H. H., & Kleihauer, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91277-7 · Cited by 102
Santisteban, I., Arredondo-Vega, F. X., Kelly, S., Mary, A., Fischer, A., Hummell, D. S., Lawton, A., Sorensen, R. U., Stiehm, E. R., & Uribe, L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116833 · Cited by 99
Morgan, R. A., Cornetta, K. G., & Anderson, W. F. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.2-135 · Cited by 91
Self-citationCloning of cDNA sequences of human adenosine deaminase.
Wiginton, D. A., Adrian, G. S., Friedman, R. L., Suttle, D. P., & Hutton, J. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7481 · Cited by 81
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency
Ochs, H. D., Buckley, R., Kobayashi, R., Kobayashi, A., Sorensen, R., Douglas, S., Bl, H., & Hershfield, M. (1992) · Blood · doi:10.1182/blood.v80.5.1163.1163 · Cited by 76
Molecular cloning of human adenosine deaminase gene sequences.
Orkin, S. H., Daddona, P. E., Shewach, D. S., Markham, A. F., Bruns, G. A. P., Goff, S. C., & Kelley, W. N. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44027-0 · Cited by 68
Wijnaendts, L. C. D., Deist, F. L., Griscelli, C., & Fischer, A. (1989) · Blood · doi:10.1182/blood.v74.6.2212.2212 · Cited by 60
Isolation of cDNA clones for human adenosine deaminase
Valerio, D., Duyvesteyn, M. G. C., Khan, P. M., van Kessel, A. G., de Waard, A., & van der Eb, A. J. (1983) · Gene · doi:10.1016/0378-1119(83)90227-5 · Cited by 56
In Vivo Expression and Survival of Gene-Modified T Lymphocytes in Rhesus Monkeys
Culver, K. W., Morgan, R. A., Osborne, W. R. A., Lee, R. T., Lenschow, D. J., Able, C., Cornetta, K. G., Anderson, W. F., & Blaese, R. M. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.4-399 · Cited by 52
Self-citationEstablishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn, D. B., Mitsuya, H., Ballow, M. C., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3971 · Cited by 42
Bone marrow transplantation in children.
Kato, S., Yabe, H., Yabe, M., Hoshi, N., Kimura, M., Noguchi, K., ARIMORI, S., Tsuji, K., Mori, T., & Yokoyama, S. (1986) · PubMed · Cited by 29
Silber, G., Winkelstein, J. A., Moen, R. C., Horowitz, S. D., Trigg, M. E., & Hong, R. (1987) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(87)90075-4 · Cited by 16
Cited by
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
The current landscape of nucleic acid therapeutics
Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & van der Meel, R. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00898-0 · Cited by 1,371
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805817 · Cited by 1,007
Metadata
- Authors
- Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., Greenblatt, J. J., Rosenberg, S. A., Klein, H., Berger, M., Mullen, C. A., Ramsey, W. J., Muul, L., Morgan, R. A., & Anderson, W. F.
- Venue
- Science
- Published
- 1995-10-20
- Volume
- 270
- Issue
- 5235
- Pages
- 475-480
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2032678451
- Cited by
- 1,550
- References
- 37
- FWCI
- 36.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.